Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
grandis (Santos et al., 2012)
The four-pathway framework of KLOW provides more comprehensive research mechanism coverage
Erythropoietic Protoporphyria (EPP) Melanotan-1 Melanotan-1 (afamelanotide/Scenesse) is the only EMA-approved treatment for EPP, with Phase 3 RCT data showing increased pain-free sun exposure and improved quality of life Vitiligo Adjunct Therapy Melanotan-1 Small RCT data shows faster and deeper repigmentation when afamelanotide implants are combined with NB-UVB phototherapy compared to phototherapy alone Photoprotection Research Melanotan-1 Melanotan-1 enhances eumelanin production and DNA repair mechanisms with a favorable safety profile established across multiple clinical trials Melanocortin Receptor Pharmacology Melanotan-2 Melanotan-2 nonselective receptor profile makes it a useful research tool for studying MC1R through MC5R signaling pathways Sexual Dysfunction Research Melanotan-2 Melanotan-2 MC4R activation produces erectogenic effects
Do not exceed the recommended daily dose, the product does not replace a varied diet and contains information on contraindications related to green tea
US$ 25.30
US$ 23.01
US$ 23.25
